CLSD - Clearside Biomedical, Inc.
0.41
-0.151 -36.902%
Share volume: 2,599,533
Last Updated: 11-28-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.56
-0.15
-0.27%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | 05-15-2025 | 08-08-2025 | 11-14-2025 | |
| Cash flow financing | 14.343 M | 0.000 | 14.000 K | 2.079 M | -553.000 K | 477.000 K | 2.905 M | |
| Other financing cash flows | 12.000 K | 0.000 | 0.000 | 0.000 | -1.000 M | -500.000 K | 2.895 M | |
| Cash flow | 6.435 M | 0.000 | -4.350 M | 6.132 M | -6.392 M | 0.000 | 0.000 | |
| Net income | -11.763 M | -7.594 M | -7.688 M | -7.307 M | -8.223 M | -4.495 M | -5.972 M | |
| Depreciation | 28.000 K | 44.000 K | 75.000 K | 79.000 K | 85.000 K | 84.000 K | 84.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -57.000 K | -11.437 M | 1.549 M | 9.307 M | -9.000 K | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 57.000 K | 423.000 K | 53.000 K | 444.000 K | 9.000 K | 0.000 | 0.000 | |
| Cash Change | 6.435 M | -17.117 M | -4.350 M | 6.132 M | -6.392 M | -4.252 M | -2.575 M |